BB-kb@ldeleger:BB-kb-15618837 / 799-1360 JSONTXT

{"project":"bionlp-ost-19-BB-kb-dev","denotations":[{"id":"T4","span":{"begin":0,"end":561},"obj":"Paragraph"},{"id":"T18","span":{"begin":18,"end":27},"obj":"Microorganism"},{"id":"T19","span":{"begin":293,"end":302},"obj":"Microorganism"}],"attributes":[{"id":"A13","pred":"NCBI_Taxonomy","subj":"T18","obj":"210"},{"id":"A14","pred":"NCBI_Taxonomy","subj":"T19","obj":"210"}],"text":"The prevalence of H. pylori infection at entry to the study was 82.2% [95% confidence interval (CI) 78-87%]. The overall eradication rate 6 weeks after treatment was 49.1% (95% CI 42.6-55.6%) by intention-to-treat analysis, and 60% (95% CI 53-67%) by per-protocol analysis. Recurrence rate of H. pylori infection at 1 year was 34% (95% CI 14-45%) and the only predictor of recurrence was an excess delta C-UBT value less than 3.5 per million but equal to or greater than 2.5 per million at 6 weeks after treatment (odds ratio 2.28; 95% CI 1.17-4.44; P = 0.028)."}